Article ID Journal Published Year Pages File Type
5702678 Urologic Oncology: Seminars and Original Investigations 2017 8 Pages PDF
Abstract
We suggest that Cβ2 mRNA expression may be used as a biomarker together with established prognostic markers to more precisely predict aggressiveness in patients diagnosed with prostate cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness
Authors
, , , , , , , , , ,